Cargando…
Biological Drugs in Guillain-Barré Syndrome: An Update
BACKGROUND: Guillain-Barré Syndrome (GBS) is currently considered the most common global cause of acute flaccid paralysis. Currently, standard therapy for Guillain-Barré Syndrome includes intravenous immunoglobulin or plasma exchange. Despite medical advances regarding these treatments, many treated...
Autores principales: | Motamed-Gorji, Nazgol, Matin, Nassim, Tabatabaie, Omidreza, Pavone, Piero, Romano, Catia, Falsaperla, Raffaele, Vitaliti, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652014/ https://www.ncbi.nlm.nih.gov/pubmed/27964705 http://dx.doi.org/10.2174/1570159X14666161213114904 |
Ejemplares similares
-
Levetiracetam in Neonatal Seizures as First-line Treatment: A Prospective Study
por: Falsaperla, Raffaele, et al.
Publicado: (2017) -
Nervous system involvement in clinical peripheral inflammation: A description of three pediatric cases
por: Vitaliti, Giovanna, et al.
Publicado: (2016) -
The Gut–brain Axis: A New Pathogenic View of Neurologic Symptoms – Description of a Pediatric Case
por: Falsaperla, Raffaele, et al.
Publicado: (2017) -
Therapeutic approaches to pediatric pseudotumor cerebri: New insights from literature data
por: Vitaliti, Giovanna, et al.
Publicado: (2017) -
Pediatric Autoimmune Encephalitis
por: Barbagallo, Massimo, et al.
Publicado: (2017)